Pharmed has sold Accuscience to Diploma PLC
Ireland and UK-based Accuscience has been sold by Pharmed to Diploma PLC.
Accuscience, based in Naas, Ireland, distributes life sciences and medtech equipment. It is a recognized leader in core market segments of the Irish healthcare sector, including clinical diagnostics, blood tracking, resuscitation and mobile/modular healthcare facilities. Through relationships with over 100 suppliers, it delivers a full continuum of value-add services in both Ireland and Northern Ireland, including to the HSE and the NHS.
Diploma is an international group supplying specialized products and services in the life sciences, seals and controls sectors across the UK, Northern Europe, North America and Australia.
Pharmed is a major healthcare and pharmaceutical services provider in Ireland and the UK offering a variety of tailor-made solutions to distribution, sales and marketing for the purpose of representing manufacturers of beauty, pharmaceutical and OTC products. With established global networks, Pharmed provides an extensive range of services to meet the strategic requirements of its partners.
Oaklins’ team in Ireland provided corporate finance advice to Pharmed in this sell-side transaction as well as overall project management services to management and the board. This was a very competitive process with a number of serious bidders from multiple jurisdictions in Europe.
Talk to the deal team
Related deals
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moreAfric Phar has been acquired by Pharma Capital
Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more